AI Summary
Thinking
Thinking
We reviewed 10 live results for exomextra and narrowed them down to the 3 options that look most worth comparing first.
The options are Single ExomeXtra®, CeGaT GmbH and ExomeXtra® Sequencing.
Source: CeGaT GmbH
Description
Single ExomeXtra is a genetic diagnostic test developed by CeGaT for patients with complex, heterogeneous, or unspecific symptoms when parental samples are unavailable. It combines whole exome sequencing, whole genome coverage for disease-relevant regions, and array-CGH resolution copy-number variant detection in a single test. The comprehensive analysis covers coding regions, non-coding disease-associated regions, mitochondrial genome, and mosaic variants, delivering an interdisciplinary medical report with clinical management recommendations within three to four weeks.
Best for
Physicians and geneticists, Patients with complex, heterogeneous, or unspecific symptoms without parental samples, Diagnosis of rare or undiagnosed genetic diseases and Single-individual exome diagnostics when parental samples are unavailable
Rate this product
Source: Unknown source
Description
CeGaT GmbH is a German biotechnology and medical diagnostics provider based in Tübingen, specializing in genetic diagnostics and next-generation sequencing (NGS) services. The laboratory offers specialized clinical solutions including Prenatal ExomeXtra trio sequencing, rare disease diagnostics, tumor analysis, prevention screening, and research pharma solutions. Accredited to CAP, CLIA, DIN EN ISO 15189, and DIN EN ISO 17025, CeGaT delivers comprehensive genetic evaluations, infection screenings, and medical reports to support clinicians, researchers, and patients worldwide.
Best for
Physicians, Clinical geneticists, Prenatal genetic diagnostics and Rare disease diagnosis
Rate this product
Source: CeGaT GmbH
Description
ExomeXtra® Sequencing by CeGaT GmbH is a next-generation sequencing service combining whole exome sequencing with targeted non-coding disease-relevant variants, copy number variation analysis, and pathogen genome detection. Performed on Illumina platforms in an accredited laboratory in Tübingen, Germany, the workflow covers library preparation, paired-end sequencing, bioinformatic analysis via Illumina DRAGEN, and structured project reporting with FASTQ deliverables in typically 15 days for research and clinical studies.
Best for
Genetic researchers, Physicians, Human disease mutation discovery and Copy number variation analysis
Rate this product
| Compare | #1Single ExomeXtra® | #2CeGaT GmbH | #3ExomeXtra® Sequencing |
|---|---|---|---|
| Source | CeGaT GmbH | Unknown source | CeGaT GmbH |
| Description | Single ExomeXtra is a genetic diagnostic test developed by CeGaT for patients with complex, heterogeneous, or unspecific symptoms when parental samples are unavailable. It combines whole exome sequencing, whole genome coverage for disease-relevant regions, and array-CGH resolution copy-number variant detection in a single test. The comprehensive analysis covers coding regions, non-coding disease-associated regions, mitochondrial genome, and mosaic variants, delivering an interdisciplinary medical report with clinical management recommendations within three to four weeks. | CeGaT GmbH is a German biotechnology and medical diagnostics provider based in Tübingen, specializing in genetic diagnostics and next-generation sequencing (NGS) services. The laboratory offers specialized clinical solutions including Prenatal ExomeXtra trio sequencing, rare disease diagnostics, tumor analysis, prevention screening, and research pharma solutions. Accredited to CAP, CLIA, DIN EN ISO 15189, and DIN EN ISO 17025, CeGaT delivers comprehensive genetic evaluations, infection screenings, and medical reports to support clinicians, researchers, and patients worldwide. | ExomeXtra® Sequencing by CeGaT GmbH is a next-generation sequencing service combining whole exome sequencing with targeted non-coding disease-relevant variants, copy number variation analysis, and pathogen genome detection. Performed on Illumina platforms in an accredited laboratory in Tübingen, Germany, the workflow covers library preparation, paired-end sequencing, bioinformatic analysis via Illumina DRAGEN, and structured project reporting with FASTQ deliverables in typically 15 days for research and clinical studies. |
| Best for | Physicians and geneticists, Patients with complex, heterogeneous, or unspecific symptoms without parental samples, Diagnosis of rare or undiagnosed genetic diseases and Single-individual exome diagnostics when parental samples are unavailable | Physicians, Clinical geneticists, Prenatal genetic diagnostics and Rare disease diagnosis | Genetic researchers, Physicians, Human disease mutation discovery and Copy number variation analysis |
| Action | CeGaT GmbH | CeGaT GmbH | CeGaT GmbH |
| Rate this product |
"Single ExomeXtra® from CeGaT GmbH."
Note: TopFind AI compiles product and service information for general comparison purposes only.
